NCT05303025

Brief Summary

The goal of this study is to explore the different attitudes and preconditions of potential end-users (doctors \& physicians in training) required to achieve successful clinical implementation of models based on artificial intelligence (i.e. both machine learning and knowledge-driven techniques) as clinical decision support software.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
69

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Apr 2022

Shorter than P25 for all trials

Geographic Reach
1 country

3 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 22, 2022

Completed
1 month until next milestone

First Posted

Study publicly available on registry

March 31, 2022

Completed
13 days until next milestone

Study Start

First participant enrolled

April 13, 2022

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 31, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 31, 2022

Completed
Last Updated

March 22, 2023

Status Verified

October 1, 2022

Enrollment Period

7 months

First QC Date

February 22, 2022

Last Update Submit

March 20, 2023

Conditions

Outcome Measures

Primary Outcomes (4)

  • Baseline attitudes towards artificial intelligence and big data in medicine

    Baseline attitudes towards artificial intelligence and big data in medicine will be collected through an online survey where participants will score their agreement with certain statements on a 6-point likert scale (Possible choices: Strongly agree - Agree - Neutral - Disagree - Totally Disagree - Not applicable).

    baseline

  • Identify subdomains of the antimicrobial stewardship cycle with potential for AI/Big data application

    Identify subdomains of the antimicrobial stewardship cycle for which participants think AI/Big data might be of use through a group discussion/interview. Reporting: frequencies.

    through study completion, an average of 1 year

  • Identify perceived potential benefits and harms when applying AI in the antimicrobial stewardship cycle.

    Identify perceived potential benefits and harms when applying AI in the antimicrobial stewardship cycle through a group discussion. Reporting: frequencies.

    through study completion, an average of 1 year

  • Identify prerequisites that need to be fulfilled when AI/Big data based clinical decision support systems are used bedside from the viewpoint of the participants.

    Identify prerequisites that need to be fulfilled when AI/Big data based clinical decision support systems are used bedside and identify the most important ones for different aspects of the antimicrobial stewardship cycle from the viewpoint of the participants through a group discussion. Reporting: frequencies.

    through study completion, an average of 1 year

Secondary Outcomes (4)

  • Subgroup analysis: age

    through study completion, an average of 1 year

  • Subgroup analysis: gender

    through study completion, an average of 1 year

  • Subgroup analysis: working environment (type of hospital, type of ICU)

    through study completion, an average of 1 year

  • Subgroup analysis: working experience (basic training and clinical experience).

    through study completion, an average of 1 year

Interventions

SurveyOTHER

Survey to acquire baseline demographic information as well as information regarding professional experience, working environment and attitudes towards artificial intelligence.

Semi-structured group discussion.

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Medical specialists or specialists in training working in intensive care at the time of the study.

You may qualify if:

  • Medical specialist or specialist in training working in intensive care at the time of the study.

You may not qualify if:

  • Age \< 18 yo

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (3)

OLV Aalst

Aalst, Belgium

Location

ZNA Ziekenhuizen

Antwerp, Belgium

Location

Ghent University Hospital

Ghent, Belgium

Location

MeSH Terms

Interventions

Surveys and Questionnaires

Intervention Hierarchy (Ancestors)

Data CollectionEpidemiologic MethodsInvestigative TechniquesHealth Care Evaluation MechanismsQuality of Health CareHealth Care Quality, Access, and EvaluationPublic HealthEnvironment and Public Health

Study Officials

  • Jan De Waele, MD, PhD

    University Ghent

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 22, 2022

First Posted

March 31, 2022

Study Start

April 13, 2022

Primary Completion

October 31, 2022

Study Completion

October 31, 2022

Last Updated

March 22, 2023

Record last verified: 2022-10

Locations